ARK Genomic Revolution UCITS ETF (ARKG)

Scheffler, Rahm, S.W. Kim, Fleetwood and Reed. 270
Thanks

Dilution non stop big scam 

OBAI, rebounding again

The recent filing might be initiated as a result of what NVIDIA defense filed or a move so that HDC does not have to show or file various information. No doubt it would seem to me that HDC's attorneys opted for this and it could be something to keep from public, yet is it good or bad?

slap&hold...................otcdark.......................................https://stockcharts.com/sc3/ui/?s=BINI&p=d&yr=0&mn=2&dy=12&id=p84071410134

Will he even mention that the Texatron belongs to a pink sheet stock??

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177707400

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=177707277

Will he mention the fraud suit??

You said: What information does the CMF use for the chartThe Chaikin Money Flow (CMF) is a technical indicator that evaluates buying and selling pressure by analyzing four core market variables over a specified period (typically 20 or 21 days):Close Price: The final trading price of the asset during

Max Resource Acquires Securities of Bolt Metals Corp.June 16, 2026 1:27 PM
NewsfileVancouver, British Columbia--(Newsfile Corp. - June

slapthatdark.........otc.............................https://stockcharts.com/sc3/ui/?s=BINI&p=d&yr=0&mn=2&dy=12&id=p84071410134

https://media.stocktwits-cdn.com/api/3/media/12965089/default.webp

33.78 so get off your butt and get us paid off

such silliness ....



1.5 million was listed on the bid and all listed as sells ....

Buy: 0 Neutral: 18,750 Sell: 1,740,300

Maybe short cover will thin out and move up sometime ...

What if he does?

CMF often shifts before the actual stock price changes direction . Bearish Divergence: Price makes a new high, but CMF makes a lower high. This signals a looming reversal.Bullish Divergence: Price hits a new low, but CMF ticks upward. This shows selling pressure is exhausting.

The Usual Suspects: Ignore the Noise

It is a predictable pattern: whenever the company gains real momentum, the same voices emerge with the same brand of alarmism. These posts are transparent attempts to obfuscate the company's progress by fixating on procedural minutiae while complet

https://x.com/NikhaarShah/status/2066861497293406631?s=20

KALA~~https://stockcharts.com/sc3/ui/?s=KALA

https://x.com/NikhaarShah/status/2066861497293406631?s=20

From https://icops2026.exordo.com/programme/presentations

Title - The RTP (Rifled Toroidal Pinch) Theory of the H-Mode in Tokamaks and its Application to the TexatronTM, John Brandenburg, MF2 - Fundamentals of Plasma Sources,10:00am, Mon 22 Jun

From https://icops2026.ex

Comparing shaz they are 74 dollars but have 1.9 mil revenue and a huge loss vs 360 mil and near term profitability. Should this be 74 dollars or higher. Both have big partners Microsoft vs nvda.

NWBO WON'T file because FDA won't accept the application because of the P3 trial. It's that simple. It's true now and will be true into the future until NWBO does another trial or has years of market experience. In either case it will be longer than NWBO has the cash to sustain itself.

KALA~~https://stockcharts.com/sc3/ui/?s=KALA

Perhaps the ST in ST3 actually means ‘Silver Tongue’ ? Showing my age with that reference…